11/1
01:05 am
nlsp
NLS Pharmaceutics (NASDAQ:NLSP) was upgraded by analysts at
Wall Street
Neutral
Report
NLS Pharmaceutics (NASDAQ:NLSP) was upgraded by analysts at
Wall Street
10/30
05:06 pm
nlsp
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger [Yahoo! Finance]
Neutral
Report
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger [Yahoo! Finance]
10/30
04:15 pm
nlsp
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
High
Report
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
10/30
07:00 am
nlsp
NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs
Medium
Report
NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs
10/29
07:00 am
nlsp
NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation Support for ITOL-102 Diabetes Program Following Merger
High
Report
NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation Support for ITOL-102 Diabetes Program Following Merger
10/29
06:00 am
nlsp
NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem
High
Report
NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem
10/29
03:53 am
nlsp
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
High
Report
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
10/27
07:00 am
nlsp
NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies
High
Report
NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies
10/23
06:01 am
nlsp
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
High
Report
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
10/6
03:30 am
nlsp
NLS Pharmaceutics (NASDAQ:NLSP) was downgraded by analysts at
Wall Stree
Medium
Report
NLS Pharmaceutics (NASDAQ:NLSP) was downgraded by analysts at
Wall Stree
9/30
07:44 am
nlsp
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting [Yahoo! Finance]
High
Report
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting [Yahoo! Finance]
9/30
07:00 am
nlsp
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
High
Report
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
9/28
03:33 am
nlsp
NLS Pharmaceutics (NASDAQ:NLSP) was upgraded by analysts at
Wall Street
Medium
Report
NLS Pharmaceutics (NASDAQ:NLSP) was upgraded by analysts at
Wall Street